NAMSR:News Claret Medical gets $18M deal to develop cerebral protection system for TAVR procedures
Claret Medical secured an $18 million in Series B financing to support development of its cerebral protection system for transcatheter aortic valve replacement.
Venture capital firm Santé Ventures led the round, with Lightstone Ventures and Easton Capital contributing extra funding.
"Many consider the stroke rate in TAVR concerning, especially as clinicians look to bring the benefits of TAVR to lower risk and younger patients," CEO Azin Parhizgar said in a statement. "The proceeds of this financing round will enable Claret Medical to conduct the SENTINEL pivotal trial, which we expect to confirm the therapeutic importance of embolic debris capture and removal during TAVR."
A fresh infusion of cash bodes well for Claret Medical, as the company continues to build its offerings and develop new cardiac products. Last July, Claret reeled in $3.6 million of an envisioned $4 million venture financing round to advance its Montage dual filter system for intravascular procedures. The company secured a CE mark for a next-generation version of the device in 2011.
Meanwhile, big names like Boston Scientific, Medtronic and Edwards Lifesciences are vying for a top spot in the TAVR playing field. In June, Medtronic won expanded FDA approval for its transcatheter heart valve for patients with severe aortic stenosis who are too frail for traditional surgical valve replacement. Days later, Edwards got a regulatory green light for a U.S. rollout of its Sapien XT device, a rival product that treats high-risk and inoperable patients. Not to be outdone, Boston Scientific won expanded European approval for its Lotus transcatheter valve system in July, strengthening its foothold in overseas markets and paving the way for full FDA approval of its product.
CANDIDATES WHO WANT TO BREAK INTO MEDICAL SALES:
RMSR® Medical Sales Certification offered by the National Association of Medical Sales Representatives is designed for entry level medical device sales reps. The course covers a wide array of topics pertaining to industry knowledge that candidates need to acquire before applying to medical sales positions.
The course and training helps to develop the industry skills, maximizing the candidates’ potential and goals, as well as making them feel valued and stimulated in their role when communicating with members of the medical community. By an applicant acquiring medical sales training and a RMSR Certification, it puts him/her in a position of strength and qualifies them for medical sales jobs. Medical knowledge is key in this industry and when communicating with doctors, surgeons, and nurses etc.
It is extremely important for representatives to use key terminology pertaining to the medical product he/she will be promoting. The only way to succeed in this industry is to garner actual sales. Doctors and Surgeons will not acknowledge a Sales Rep who is not proficient in essential medical terminology, knowledgeable of medical devices/equipment and the anatomy. For those lacking a solid sales background the RMSR course covers knowledge of medical selling techniques and regulation such as Effective Territory Management, Effective Networking, Medical Sales Ethical & Regulatory Guidelines and more.
The National Association of Medical Sales Representative™
For more information on the NAMSR or the RMSR certification visit www.medicalsalescareer.com or call 800-313-9198